Contact Us
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization

Picture of Guest User Guest User Jun 12, 2017 10:53:28 AM

Immunology Cell Adhesion Tumor Microenvironment Cytokine Cell Migration/Invasion Cellular Analysis

ACCESS TO ARTICLE →